{"DataElement":{"publicId":"4785672","version":"1","preferredName":"Route of Administration Performed Type","preferredDefinition":"The path or method through which a product is administered into the body.","longName":"ROA_PERF_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"4783887","version":"1","preferredName":"Route of Administration Performed","preferredDefinition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration._Executed and carried through to completion.","longName":"2452897v1.0:2241241v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2452897","version":"1","preferredName":"Route of Administration","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.","longName":"C38114","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6BC0-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"ONEDATA","dateModified":"2006-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1338F4DC-CDA4-6484-E050-BB89AD437EA8","latestVersionIndicator":"Yes","beginDate":"2015-04-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"4/28/15 Released. jc  4/8/15 created per work of ROA Harmonization WG. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4784372","version":"1","preferredName":"Route of Administration Type","preferredDefinition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration._Something distinguishable as an identifiable class based on common qualities.","longName":"ROA_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intraperitoneal","valueDescription":"Intraperitoneal Route of Administration","ValueMeaning":{"publicId":"2578020","version":"1","preferredName":"Intraperitoneal Route of Administration","longName":"2578020","preferredDefinition":"Administration within the peritoneal cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraperitoneal Route of Administration","conceptCode":"C38258","definition":"Administration of a drug via injection or infusion of a substance into the peritoneum, where it is absorbed by the lining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDD1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A1DD2-8F7B-B35F-E050-BB89AD433CEE","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Oral","valueDescription":"Oral","ValueMeaning":{"publicId":"2562296","version":"1","preferredName":"Oral","longName":"2562296","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B3D-55B8-E050-BB89AD430890","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Rectal","valueDescription":"Rectal Route of Administration","ValueMeaning":{"publicId":"2581011","version":"1","preferredName":"Rectal Route of Administration","longName":"2581011","preferredDefinition":"The introduction of a substance into the gastrointestinal tract by the way of the rectum, usually for systemic action. Depending on the molecular structure, drugs cross the rectal wall via either intercellular or tight junctions interconnecting the mucosal cells. Drug absorption is usually around 50% of normal oral dose. Due to the drainage pattern of the rectal veins, the hepatic first-pass effect tends to increase as the dosage form is placed deeper into the rectum. Solid suppositories represent greater than 98% of all rectal dosage forms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Route of Administration","conceptCode":"C38295","definition":"The introduction of a substance into the gastrointestinal tract by the way of the rectum, usually for systemic action. Depending on the molecular structure, drugs cross the rectal wall via either intercellular or tight junctions interconnecting the mucosal cells. Drug absorption is usually around 50% of normal oral dose. Due to the drainage pattern of the rectal veins, the hepatic first-pass effect tends to increase as the dosage form is placed deeper into the rectum. Solid suppositories represent greater than 98% of all rectal dosage forms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0980-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B47-55B8-E050-BB89AD430890","beginDate":"2003-12-31","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Subcutaneous","valueDescription":"Subcutaneous Route of Administration","ValueMeaning":{"publicId":"2578038","version":"1","preferredName":"Subcutaneous Route of Administration","longName":"2578038","preferredDefinition":"Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subcutaneous Route of Administration","conceptCode":"C38299","definition":"Drug administration beneath the skin. It provides for relatively slow, sustained release of the drug. The rate of absorption into the blood is perfusion-limited, proportional to the amount of drug at the site and can be enhanced by chemical or physical stimulation of blood flow. Subcutaneous administration minimizes the risks associated with intravascular injection: for subcutaneous infusions, external and implantable pumps are used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B52-55B8-E050-BB89AD430890","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Sublingual","valueDescription":"Sublingual Route of Administration","ValueMeaning":{"publicId":"2577977","version":"1","preferredName":"Sublingual Route of Administration","longName":"2577977","preferredDefinition":"Administration beneath the tongue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sublingual Route of Administration","conceptCode":"C38300","definition":"Administration of a drug beneath the tongue. The route provides rapid absorption, the drug immediately enters the bloodstream without first passing through the intestinal wall and liver. However, most drugs cannot be taken this way because they may be absorbed incompletely or erratically.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B5D-55B8-E050-BB89AD430890","beginDate":"2005-09-27","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Topical","valueDescription":"Topical Route of Administration","ValueMeaning":{"publicId":"2577941","version":"1","preferredName":"Topical Route of Administration","longName":"2577941","preferredDefinition":"The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue locally, so that the agent will take effect on the surface and/or on the underlying tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Topical Route of Administration","conceptCode":"C38304","definition":"The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue locally, so that the agent will take effect on the surface and/or on the underlying tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD82-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B68-55B8-E050-BB89AD430890","beginDate":"2004-02-02","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Transdermal","valueDescription":"Transdermal Route of Administration","ValueMeaning":{"publicId":"2581012","version":"1","preferredName":"Transdermal Route of Administration","longName":"2581012","preferredDefinition":"Administration of a substance through the dermal layer of the skin into the systemic circulation by diffusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transdermal Route of Administration","conceptCode":"C38305","definition":"Administration of a substance through the dermal layer of the skin into the systemic circulation by diffusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0981-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B73-55B8-E050-BB89AD430890","beginDate":"2005-09-27","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown Route of Administration","ValueMeaning":{"publicId":"4633411","version":"1","preferredName":"Unknown Route of Administration","longName":"4633411","preferredDefinition":"The route of drug administration is unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown Route of Administration","conceptCode":"C38311","definition":"The route of drug administration is unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A42DC54-D3EF-6CA0-E050-BB89AD431B37","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0B7E-55B8-E050-BB89AD430890","beginDate":"2006-04-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Intrauterine","valueDescription":"Intrauterine Route of Administration","ValueMeaning":{"publicId":"4784374","version":"1","preferredName":"Intrauterine Route of Administration","longName":"4784374","preferredDefinition":"Administration within the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrauterine Route of Administration","conceptCode":"C38272","definition":"The administration of a drug within the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A0270-1519-BE2D-E050-BB89AD434944","latestVersionIndicator":"Yes","beginDate":"2015-04-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0BD2-55B8-E050-BB89AD430890","beginDate":"2013-02-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Intraurethral","valueDescription":"Intraurethral Route of Administration","ValueMeaning":{"publicId":"2577935","version":"1","preferredName":"Intraurethral Route of Administration","longName":"2577935","preferredDefinition":"Administration of a drug directly into the urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraurethral Route of Administration","conceptCode":"C38271","definition":"Administration of a drug directly into the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13528814-0BE6-55B8-E050-BB89AD430890","beginDate":"2013-02-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Route of Administration","ValueMeaning":{"publicId":"3698078","version":"1","preferredName":"Other Route of Administration","longName":"3698078","preferredDefinition":"Route of drug administration not specified on this list.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Route of Administration","conceptCode":"C38290","definition":"Route of drug administration not specified on this list.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7F87591-0676-A535-E040-BB89AD437E5F","latestVersionIndicator":"Yes","beginDate":"2013-03-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-46FC-F729-E050-BB89AD432860","beginDate":"2015-04-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Intraarticular","valueDescription":"Intraarticular Route of Administration","ValueMeaning":{"publicId":"2577992","version":"1","preferredName":"Intraarticular Route of Administration","longName":"2577992","preferredDefinition":"Administration within a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarticular Route of Administration","conceptCode":"C38223","definition":"Administration of the drug within a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-4707-F729-E050-BB89AD432860","beginDate":"2015-04-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Intrathecal","valueDescription":"Intrathecal","ValueMeaning":{"publicId":"2574002","version":"1","preferredName":"Intrathecal","longName":"2574002","preferredDefinition":"Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Route of Administration","conceptCode":"C38267","definition":"Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE1F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-471C-F729-E050-BB89AD432860","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Intravenous","valueDescription":"Intravenous Route of Administration","ValueMeaning":{"publicId":"2578035","version":"1","preferredName":"Intravenous Route of Administration","longName":"2578035","preferredDefinition":"Administration within or into a vein or veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-4726-F729-E050-BB89AD432860","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Nasal","valueDescription":"Nasal Route of Administration","ValueMeaning":{"publicId":"2660005","version":"1","preferredName":"Nasal Route of Administration","longName":"2660005","preferredDefinition":"Administration of a drug by the way of the nose. This often results in systemic action of the agent due to absorption through the nasal mucosa. The richly supplied vascular nature of the nasal mucosa coupled with its high drug permeation makes the nasal route of administration attractive for many drugs, including proteins and peptides.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal Route of Administration","conceptCode":"C38284","definition":"Administration of a drug by the way of the nose. This often results in systemic action of the agent due to absorption through the nasal mucosa. The richly supplied vascular nature of the nasal mucosa coupled with its high drug permeation makes the nasal route of administration attractive for many drugs, including proteins and peptides.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BEA2A0-DE70-6CE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-4772-F729-E050-BB89AD432860","beginDate":"2004-02-02","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Nasogastric","valueDescription":"Nasogastric","ValueMeaning":{"publicId":"2568390","version":"1","preferredName":"Nasogastric","longName":"2568390","preferredDefinition":"Administration through the nose and into the stomach, usually by means of a tube.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasogastric Route of Administration","conceptCode":"C38285","definition":"Administration of a drug through the nose and into the stomach, usually by means of a tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D833-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-09","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-4787-F729-E050-BB89AD432860","beginDate":"2004-02-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Ophthalmic","valueDescription":"Ophthalmic Route of Administration","ValueMeaning":{"publicId":"2577938","version":"1","preferredName":"Ophthalmic Route of Administration","longName":"2577938","preferredDefinition":"Administration of a drug to the external eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ophthalmic Route of Administration","conceptCode":"C38287","definition":"Administration of a drug to the external surfaces of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"134C6F32-4791-F729-E050-BB89AD432860","beginDate":"2004-02-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-09","modifiedBy":"ONEDATA","dateModified":"2015-04-09","deletedIndicator":"No"},{"value":"Dermal","valueDescription":"Cutaneous Route of Administration","ValueMeaning":{"publicId":"2577979","version":"1","preferredName":"Cutaneous Route of Administration","longName":"2577979","preferredDefinition":"Administration to the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Route of Administration","conceptCode":"C38675","definition":"Administration to the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-1490-BE2D-E050-BB89AD434944","beginDate":"2015-04-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Endotracheal","valueDescription":"Endotracheal Route of Administration","ValueMeaning":{"publicId":"2577075","version":"1","preferredName":"Endotracheal Route of Administration","longName":"2577075","preferredDefinition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endotracheal Route of Administration","conceptCode":"C38208","definition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA20-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-149B-BE2D-E050-BB89AD434944","beginDate":"2005-11-23","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Gastrostomy","valueDescription":"Gastrostomy Tube","ValueMeaning":{"publicId":"2569955","version":"1","preferredName":"Gastrostomy Tube","longName":"2569955","preferredDefinition":"Drug administration through a gastric fistula or a surgically created artificial opening into the stomach through the abdominal wall with insertion of a tube.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration via Gastrostomy","conceptCode":"C38199","definition":"Drug administration through a gastric fistula or a surgically created artificial opening into the stomach through the abdominal wall with insertion of a tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DE50-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-07","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-14B2-BE2D-E050-BB89AD434944","beginDate":"2004-06-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intraarterial","valueDescription":"Intraarterial Route of Administration","ValueMeaning":{"publicId":"2578037","version":"1","preferredName":"Intraarterial Route of Administration","longName":"2578037","preferredDefinition":"Administration within an artery or arteries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarterial Route of Administration","conceptCode":"C38222","definition":"The administration of a substance directly into an artery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-14BF-BE2D-E050-BB89AD434944","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intradermal","valueDescription":"Intradermal Route of Administration","ValueMeaning":{"publicId":"2578084","version":"1","preferredName":"Intradermal Route of Administration","longName":"2578084","preferredDefinition":"Administration within the dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intradermal Route of Administration","conceptCode":"C38238","definition":"Intradermal injection is a method of drug administration within the substance of the skin, particularly the dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE11-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-03-01","modifiedBy":"ONEDATA","dateModified":"2006-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-14CA-BE2D-E050-BB89AD434944","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intrahepatic","valueDescription":"Intrahepatic Route of Administration","ValueMeaning":{"publicId":"3629942","version":"1","preferredName":"Intrahepatic Route of Administration","longName":"3629942","preferredDefinition":"Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic Route of Administration","conceptCode":"C38248","definition":"Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-845F-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-14D5-BE2D-E050-BB89AD434944","beginDate":"2002-08-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intramuscular","valueDescription":"Intramuscular Route of Administration","ValueMeaning":{"publicId":"2578009","version":"1","preferredName":"Intramuscular Route of Administration","longName":"2578009","preferredDefinition":"Administration within a muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramuscular Route of Administration","conceptCode":"C28161","definition":"Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-14E0-BE2D-E050-BB89AD434944","beginDate":"2004-01-27","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Inhalation","valueDescription":"Inhalation Route of Administration","ValueMeaning":{"publicId":"2577932","version":"1","preferredName":"Inhalation Route of Administration","longName":"2577932","preferredDefinition":"Administration of a substance in the form of a gas, aerosol, or fine powder via the respiratory tract, usually by oral or nasal inhalation, for local or systemic effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inhalation Route of Administration","conceptCode":"C38216","definition":"Administration of a substance in the form of a gas, aerosol, or fine powder via the respiratory tract, usually by oral or nasal inhalation, for local or systemic effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-14EB-BE2D-E050-BB89AD434944","beginDate":"2004-02-09","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Interstitial","valueDescription":"Interstitial Route of Administration","ValueMeaning":{"publicId":"4784373","version":"1","preferredName":"Interstitial Route of Administration","longName":"4784373","preferredDefinition":"Administration to or in the interstices of a tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interstitial Route of Administration","conceptCode":"C38219","definition":"Drug administration to or in the interstices of a tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A0270-14F6-BE2D-E050-BB89AD434944","latestVersionIndicator":"Yes","beginDate":"2015-04-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-150F-BE2D-E050-BB89AD434944","beginDate":"2006-04-03","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intraventricular","valueDescription":"Intraventricular Route of Administration","ValueMeaning":{"publicId":"2578016","version":"1","preferredName":"Intraventricular Route of Administration","longName":"2578016","preferredDefinition":"Administration within a ventricle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraventricular Route of Administration","conceptCode":"C38277","definition":"Administration of a drug directly into a cerebral ventricle, commonly using a reservoir. This allows a more even distribution of drug through the cerebrospinal fluid (CSF) and is particularly useful in the treatment of certain types of cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDCD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-153C-BE2D-E050-BB89AD434944","beginDate":"2007-07-25","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intravesical","valueDescription":"Intravesical Route of Administration","ValueMeaning":{"publicId":"2577982","version":"1","preferredName":"Intravesical Route of Administration","longName":"2577982","preferredDefinition":"Administration within the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravesical Route of Administration","conceptCode":"C38278","definition":"The administration of a drug within the urinary bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-1547-BE2D-E050-BB89AD434944","beginDate":"2010-07-29","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Intratumoral","valueDescription":"Intratumoral Route of Administration","ValueMeaning":{"publicId":"2578029","version":"1","preferredName":"Intratumoral Route of Administration","longName":"2578029","preferredDefinition":"The administration of a drug within or introduced directly into a tumor. Method allows to achieve high concentration of the agent in the tumor and delay drug release in systemic circulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral Route of Administration","conceptCode":"C38269","definition":"The administration of a drug within or introduced directly into a tumor. Method allows to achieve high concentration of the agent in the tumor and delay drug release in systemic circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDDA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-1552-BE2D-E050-BB89AD434944","beginDate":"2005-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Otic","valueDescription":"Auricular Route of Administration","ValueMeaning":{"publicId":"2576423","version":"1","preferredName":"Auricular Route of Administration","longName":"2576423","preferredDefinition":"Administration to or by way of the ear.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Auricular Route of Administration","conceptCode":"C38192","definition":"Administration of the drug to or by way of the ear. The drug action is mostly topical/local.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F794-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-04","modifiedBy":"ONEDATA","dateModified":"2005-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-15CB-BE2D-E050-BB89AD434944","beginDate":"2005-10-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Transmucosal","valueDescription":"Transmucosal Route","ValueMeaning":{"publicId":"2635256","version":"1","preferredName":"Transmucosal Route","longName":"2635256","preferredDefinition":"Administration of a substance to the mucosa; often resulting in systemic action due to absorption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucosal Route of Administration","conceptCode":"C38283","definition":"Administration of a substance to the mucosa; often resulting in systemic action due to absorption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6E8C91-335A-4FD7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-1639-BE2D-E050-BB89AD434944","beginDate":"2007-05-01","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"},{"value":"Vaginal","valueDescription":"Vaginal Route","ValueMeaning":{"publicId":"2575266","version":"1","preferredName":"Vaginal Route","longName":"2575266","preferredDefinition":"Relating to the vagina or to any sheath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal","conceptCode":"C13309","definition":"Of or relating to the vagina.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F30F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-02","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"133A0270-165A-BE2D-E050-BB89AD434944","beginDate":"2005-06-02","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"ONEDATA","dateModified":"2015-04-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2486825","version":"1","preferredName":"Route of Administration Type","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.:Type; a subdivision of a particular kind of thing.","longName":"C38114:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16358911-63C0-2575-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-14","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-14","modifiedBy":"ONEDATA","dateModified":"2006-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A0270-1471-BE2D-E050-BB89AD434944","latestVersionIndicator":"Yes","beginDate":"2015-04-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"CHILLIJ","dateModified":"2015-04-28","changeDescription":"4/28/15 Released. jc  4/8/15 value list extensible - use CUI FDA term definition in caDSR.  VD created per work of ROA Harmonization WG; harmonizes VMs in Standards 2003586 and 62589. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Route","type":"Preferred Question Text","description":"Route","url":null,"context":"NCIP"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"133A1DD2-8F86-B35F-E050-BB89AD433CEE","latestVersionIndicator":"Yes","beginDate":"2015-04-08","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-08","modifiedBy":"CHILLIJ","dateModified":"2015-04-28","changeDescription":"4/28/15 Released; chg reg status to Qualifed. jc  4/8/15 created based on ROA Harmonization WG; to replace existing Standards 2003586, 62589. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}